PinderR.M.BrodgenR.N.SpeightT.M., and AveryG.S., Sodium Valproate: A Review of its Pharmacological Properties and Therapeutic Efficacy in Epilepsy, Drugs, 13:81–123, 1977.
2.
KeysP.A., Valproic Acid: Interactions with Phenytoin and Phenobarbital, Drug Intell. Clin. Pharmacol., 16:737–739, 1982.
3.
LevyR.H., and KochK.M., Drug Interactions with Valproic Acid, Drugs, 24:543–556, 1982.
4.
LundeP.K.M.RaneA.YalleS.J.LundL., and SjogvistF., Plasma Protein Binding of Diphenylhydantoin, Man. Clin. Pharmacol. Ther., 11:846–855, 1970.
5.
GramL.FlachsE.JorgensenA.ParnasO., and AndersonB., Sodium Valproate, Serum Level, and Clinical Effect in Epilepsy: A Controlled Study, Epilepsia, 20:303–312, 1979.
6.
RichensA.ScoularI.T.AhmandS., and JordanB.J.The Effects of Sodium Valproate (Epilim) on Phenytoin and Phenobarbitone Blood Levels. In Leggs (Ed.), Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, MCS Consultants, Tunbridge Wells, 1976, pp. 78–88.
7.
VajdaF.MorrisP.DrummerO., and BladinP., Studies on Sodium Valproate - A New Anticonvulsant. In Legg (Ed.), Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, MCS Consultants, Turnbridge Wells, 1976, pp. 92–100.
8.
BardyA.HariR.LehtovaaraR., and MajuriH., Valproate May Lower Serum Phenytoin, Lancet, 1:1256–1257, 1976.
9.
MonksA., and RichensA., Effects of a Single Dose of Sodium Valproate on Serum Phenytoin Levels and Protein Binding in Epileptic Patients, Clin. Pharmacol. Ther., 27:89–95, 1980.
10.
MattsonR.H.CramerJ.A.WilliamsonP.D., and NovellyR., Valproic Acid In Epilepsy: Clinical and Pharmacological Effects, Ann. Neurol., 3:20–25, 1978.
11.
GramL.WulffK.RasmussenK.E.FlachsH.Wurtz-JorgensenA.SommerbeckK.W., and LohienV., Valproate Sodium: A Controlled Clinical Trial Including Monitoring of Drug Levels, Epilepsia, 18 (2), 1977.
12.
BruniJ.GalloJ.M.LeeC.S.PerchalskR.S., and WilderB.J., Interactions of Valproic Acid with Phenytoin, Neurology, 30:1233–36, 1980.
13.
VakilS.D.CrichtleyE.M.R.PhillipsJ.C.FahimY.HaydockC.CocksA., and DyerT., Effect of Sodium Valproate (Epilim) on Phenytoin and Phenobarbitone Blood Levels. In Legg (Ed.). Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, MCS Consultant, Tunbridge Wells, 1976, pp. 75–77.
14.
WindoferA.SauerW., and GadekeR., Elevation of Diphenylhydantoin and Primidone Serum Concentration by Addition of Dipropylacetate, a New Anticonvulsant Drug, Acta Paediatr. Scand., 64:771–775, 1975.
15.
PeruccaE.HebdigeS.FrigoG.M.GattiG.LecchiniS., and CremaA., Interaction Between Phenytoin and Valproic Acid: Plasma Protein Binding and Metabolic Effects, Clin. Pharmacol. Ther., 28 (6), 1980.
16.
LoiseauP.BrachetA., and HenryP., Concentration of Dipropylacetate in Plasma, Epilepsia, 16:609–15, 1975.
17.
BookerH.E., and DarceyB., Serum Concentration of Free Diphenylhydantoin and Their Relationship to Clinical Intoxication, Epilepsia, 14:177–184, 1973.
18.
EadieM.J., Plasma Level Monitoring of Anticonvulsants, Clin. Pharmacokin., 1:52–66, 1976.
19.
KoberA.OlssonY., and SjoholmI., Bindings of Drugs to Human Serum Albumin. The Theoretical Basis for the Interaction Between Phenytoin and Valproate, Mol. Pharmacol., 18:237–242, 1980.
20.
CramerJ.A., and MattsonR.H., Valproic Acid: In Vitro Plasma Protein Binding and Interactions with Phenytoin, Therapeutic Drug Monitoring, 1:105–116, 1979.